Suppr超能文献

病毒性肝炎的历史与全球负担

History and Global Burden of Viral Hepatitis.

作者信息

Blum Hubert E

机构信息

Internal Medicine II, University Hospital Freiburg, Freiburg, Germany.

出版信息

Dig Dis. 2016;34(4):293-302. doi: 10.1159/000444466. Epub 2016 May 11.

Abstract

Between 1963 and 1989, 5 hepatotropic viruses have been discovered that are the major causes of viral hepatitides worldwide: hepatitis A virus, hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis delta virus and hepatitis E virus. Their epidemiology and pathogenesis have been studied in great detail. Furthermore, the structure and genetic organization of their DNA or RNA genome including the viral life cycle have been elucidated and have been successfully translated into important clinical applications, such as the specific diagnosis, therapy and prevention of the associated liver diseases, including liver cirrhosis and hepatocellular carcinoma (HCC). The prevalence of acute and chronic viral hepatitis A-E shows distinct geographic differences. The global burden of disease (prevalence, incidence, death, disability-adjusted life years) has been analyzed in seminal studies that show that the worldwide prevalence of hepatitis A-E has significantly decreased between 1990 and 2013. During the same time, the incidence of HBV-related liver cirrhosis and HCC, respectively, also decreased or increased slightly, the incidence of the HCV-related liver cirrhosis remained stable and the incidence of HCV-related HCC showed a major increase. During the coming years, we expect to improve our ability to prevent and effectively treat viral hepatitis A-E, resulting in the control of these global infections and the elimination of their associated morbidities and mortalities.

摘要

1963年至1989年间,已发现5种嗜肝病毒,它们是全球病毒性肝炎的主要病因:甲型肝炎病毒、乙型肝炎病毒(HBV)、丙型肝炎病毒(HCV)、丁型肝炎病毒和戊型肝炎病毒。对它们的流行病学和发病机制进行了详细研究。此外,它们的DNA或RNA基因组的结构和基因组织,包括病毒生命周期,已得到阐明,并已成功转化为重要的临床应用,如相关肝脏疾病(包括肝硬化和肝细胞癌(HCC))的特异性诊断、治疗和预防。甲型至戊型急性和慢性病毒性肝炎的流行情况存在明显的地域差异。在一些开创性研究中分析了全球疾病负担(患病率、发病率、死亡率、伤残调整生命年),结果显示,1990年至2013年间,甲型至戊型肝炎的全球患病率显著下降。与此同时,HBV相关肝硬化和HCC的发病率分别有所下降或略有上升,HCV相关肝硬化的发病率保持稳定,而HCV相关HCC的发病率大幅上升。在未来几年,我们期望提高预防和有效治疗甲型至戊型病毒性肝炎的能力,从而控制这些全球感染,并消除其相关的发病率和死亡率。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验